← Leaderboards
Alexey G. Ryazanov
Univ Of Med/Dent Nj-R W Johnson Med Sch
$7,737,698
Attributed
$7,737,698
Total exposure
10
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3M · FY2005–15$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$16,480,568 · 11
By mechanism
P01$10,479,858 · 3
R01$3,893,836 · 3
RC1$1,068,667 · 1
R41$444,026 · 2
R21$425,069 · 1
R03$169,112 · 1
Top collaborators
No co-investigators on record.
Most similar at Univ Of Med/Dent Nj-R W Johnson Med Sch
Same institution · by research overlap
- Bing Xia$11,519,463
- Ling Qin$10,712,593
- Terri Goss Kinzy$7,949,810
- Paul E Thomas$2,351,798
Others in their field
Top investigators on “Protein Biosynthesis”
- Kent J. Weinhold · Duke University$39,902,311
- Myron Fredric Goodman · University Of Southern California$21,511,591
- Craig A Townsend · Johns Hopkins University$20,563,122
- Bruce W Stillman · Cold Spring Harbor Laboratory$20,241,203
- Dieter G Soll · Yale University$20,125,460
- K. Sreekumaran Nair · University Of Vermont &St Agric College$19,973,818
Research focus
Protein BiosynthesisPhosphorylationProtein KinasePhosphotransferasesApoptosisTranslation FactorRegulationResearch StudyCellsPharmaceutical PreparationsResistancePeptide LibraryCalmodulin-Dependent Protein Kinase IiiTissuesLaboratory MouseGene TargetingProgramsMonitorEmbryoCollaborationsEnzyme ActivityMediatingCaenorhabditis ElegansLead
Grant awards (34)
Use of EF2K inhibitors to inhibit tumor growth and sensitize cancer cells to existing chemotherapy treatment$221,987
R41 · FY2015 · CA · contact PI
Use of EF2K Inhibitors to Reduce Toxicity to Normal Tissues in Chemotherapy$222,039
R41 · FY2014 · CA · contact PI
Investigation of synergism between mTOR and eEF2 kinase pathways$187,819
R21 · FY2013 · AG · contact PI
Investigation of synergism between mTOR and eEF2 kinase pathways$237,249
R21 · FY2012 · AG · contact PI
Translational Control of Radiation-Induced Apoptosis$54,023
R03 · FY2012 · TW · contact PI
Investigation of synergism between mTOR and eEF2 kinase pathways$1
R21 · FY2012 · AG · contact PI
Regulation of Metal Ion Homeostasis by Channel Kinases$1,721,529
P01 · FY2011 · GM · contact PI
Project 2: Structure Function of TRPM6/7 Alpha Kinase Domains$343,392
P01 · FY2011 · GM · contact PI
Translational Control of Radiation-Induced Apoptosis$54,022
R03 · FY2011 · TW · contact PI
Regulation of Metal Ion Homeostasis by Channel Kinases$1,749,925
P01 · FY2010 · GM · contact PI
Project 2: Structure Function of TRPM6/7 Alpha Kinase Domains$346,772
P01 · FY2010 · GM · contact PI
Translational Control of Radiation-Induced Apoptosis$61,067
R03 · FY2010 · TW · contact PI
Regulation of Metal Ion Homeostasis by Channel Kinases$1,727,339
P01 · FY2009 · GM · contact PI
Project 2: Structure Function of TRPM6/7 Alpha Kinase Domains$339,982
P01 · FY2009 · GM · contact PI
Development of New Drugs that Protect Gastrointestinal Tract from Radiation$318,667
RC1 · FY2009 · AI · contact PI
Regulation of Metal Ion Homeostasis by Channel Kinases$1,691,050
P01 · FY2008 · GM · contact PI
Project 2: Structure Function of TRPM6/7 Alpha Kinase Domains$329,853
P01 · FY2008 · GM · contact PI
Regulation of Metal Ion Homeostasis by Channel Kinases$1,853,027
P01 · FY2007 · GM · contact PI
Development of New Drugs that Protect Gastrointestinal Tract from Radiation$750,000
RC1 · FY2007 · AI · contact PI
Project 2: Structure Function of TRPM6/7 Alpha Kinase Domains$332,836
P01 · FY2007 · GM · contact PI
Core A: Administrative Support$44,153
P01 · FY2007 · GM · contact PI
THE ROLE OF PROTEIN TURNOVER IN AGING$392,500
R01 · FY2005 · AG
THE ROLE OF PROTEIN TURNOVER IN AGING$392,500
R01 · FY2004 · AG
THE ROLE OF PROTEIN TURNOVER IN AGING$392,500
R01 · FY2003 · AG
STRUCTURE/FUNCTION OF EFF-2 KINASE$262,113
R01 · FY2003 · GM
THE ROLE OF EF-2 KINASE IN DRUG RESISTANCE$239,434
R01 · FY2003 · CA
THE ROLE OF PROTEIN TURNOVER IN AGING$392,500
R01 · FY2002 · AG
STRUCTURE/FUNCTION OF EFF-2 KINASE$254,570
R01 · FY2002 · GM
THE ROLE OF EF-2 KINASE IN DRUG RESISTANCE$232,460
R01 · FY2002 · CA
THE ROLE OF PROTEIN TURNOVER IN AGING$375,970
R01 · FY2001 · AG
STRUCTURE/FUNCTION OF EFF-2 KINASE$247,250
R01 · FY2001 · GM
THE ROLE OF EF-2 KINASE IN DRUG RESISTANCE$225,686
R01 · FY2001 · CA
STRUCTURE/FUNCTION OF EFF-2 KINASE$252,389
R01 · FY2000 · GM
THE ROLE OF EF-2 KINASE IN DRUG RESISTANCE$233,964
R01 · FY2000 · CA